Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1932 (LINC01932) is a non-protein coding gene belonging to the family of long intergenic non-coding RNAs (lincRNAs), which are defined as RNA transcripts longer than 200 nucleotides that do not overlap with annotated protein-coding genes. LincRNAs share structural characteristics with other long non-coding RNAs and are generally involved in the regulation of gene expression at various levels, including modulation of chromatin structure, transcriptional regulation, RNA stabilization, and sometimes enhancer-like functions. However, as of current knowledge and public genomic resources, there is no direct evidence that LINC01932 is involved in disease, is druggable, or is considered a therapeutic target. The classification and nomenclature of LINC01932 are based on its annotated sequence and non-protein-coding status, and its precise biological function and relevance remain uncharacterized in the scientific literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1932 (LINC01932).